应用化学 ›› 2021, Vol. 38 ›› Issue (5): 592-604.DOI: 10.19894/j.issn.1000-0518.210099

• 综合评述 • 上一篇    

病原微生物的核酸检测分析研究进展

李子玥1, 杨同仁1, 杨歌1, 黄渊余1,2*   

  1. 1北京理工大学生命学院;前沿交叉科学研究院;分子医学与生物诊疗重点实验室,北京 100081
    2北京理工大学珠海学院,材料与环境学院,珠海 519085
  • 收稿日期:2021-03-08 接受日期:2021-04-09 出版日期:2021-05-01 发布日期:2021-07-01
  • 通讯作者: *E-mail:yyhuang@bit.edu.cn
  • 基金资助:
    国家自然科学基金(No.31871003)、北京市科技新星(No.Z201100006820005)和广东省自然科学基金(No.2019A1515010776)资助

Research Progresses of Nucleic Acid Based Detection of Pathogenic Microorganisms

LI Zi-Yue1, YANG Tong-Ren1, YANG Ge1, HUANG Yuan-Yu1,2*   

  1. 1School of Life Science, Advanced Research Institute of Multidisciplinary Science; Key Laboratory of Molecular Medicine and Biotherapy; Beijing Institute of Technology, Beijing 100081, China
    2School of Materials and the Environment, Beijing Institute of Technology, Zhuhai 519085, China
  • Received:2021-03-08 Accepted:2021-04-09 Published:2021-05-01 Online:2021-07-01
  • Supported by:
    National Natural Science Foundation of China (No.31871003), Beijing Nova Program from Beijing Municipal Science & Technology Commission (No.Z201100006820005) and the Natural Science Foundation of Guangdong Province (No.2019A1515010776)

摘要: 2019年12月,全球爆发新型冠状病毒肺炎疫情(COVID-19),使生物安全面临着巨大危机。 病原微生物的快速、准确、低成本检测是保障生物安全的重要组成元素之一,是疫情预防、控制和诊断的关键。 本综述介绍了核酸测序技术、等温扩增技术和基因编辑技术(CRISPR/Cas)于便携式一体化设备中的应用,为研发“低成本,高效率,结果可视化”集成式检测方法提供了可能性,旨在为病原微生物的有效防控提供保障。

关键词: 核酸, 快速检测, 病原微生物, 新型冠状病毒, 基因编辑技术

Abstract: In December 2019, the global outbreak of Corona Virus Disease 2019 (COVID-19)made biosafety an attractive and crucial development direction globally. Rapid, accurate and low-cost detection of pathogenic microorganisms is one of the important issue to ensure biosafety, and is the key to epidemic prevention, control and diagnosis. This review elaborately introduces the applications of biosensors based on nucleic acid sequencing, isothermal amplification and gene editing (CRISPR/Cas) in integrated portable devices. The development of these technologies offers the possibility of developing “low-cost, high-efficiency and result-visualization” integrated detection methods. It is expected to provide technology guarantees for the effective prevention and control of pathogenic microorganisms.

Key words: Nucleic acid, Rapid detection, Pathogenic microorganisms, SARS-CoV-2, CRISPR/Cas

中图分类号: